This study with tumor-based HPV16 status and a homogenous subgroup of SCCHN patients would help more accurately evaluate the associations between the p53 and p73 polymorphisms and tumor HPV16-positive oropharyngeal cancers. Here, TP53 is linked to head and neck squamous cell carcinoma.